论文部分内容阅读
目的:观察应用痰热清注射液联合阿奇霉素治疗肺炎支原体肺炎患儿的临床效果。方法:将100例肺炎支原体肺炎患儿按照随机数字表法分成观察组与对照组各50例,2组患儿均给予常规对症治疗,在此基础上,观察组给予痰热清注射液联合阿奇霉素治疗,对照组给予阿奇霉素治疗,观察2组患儿的临床症状、实验室指标、X线检查结果的变化,不良反应发生情况及发热消退时间、啰音消失时间、咳嗽消失时间等。结果:总有效率观察组为98.00%,对照组为80.00%,2组总有效率比较,差异有统计学意义(P<0.05)。观察组发热消退时间、啰音消失时间及咳嗽消失时间分别与对照组比较,差异均有统计学意义(P<0.01)。观察组不良反应发生率为12.00%,显著低于对照组的30.00%,差异有统计学意义(P<0.05)。结论:应用痰热清注射液联合阿奇霉素治疗肺炎支原体肺炎患儿,可有效提高治疗效果,且症状缓解快、不良反应少,具有较高的应用价值。
Objective: To observe the clinical effect of Tanreqing injection combined with azithromycin in children with Mycoplasma pneumoniae pneumonia. Methods: 100 cases of children with Mycoplasma pneumoniae pneumonia were randomly divided into observation group and control group according to random number table method, 50 cases in each group. All the patients were given conventional symptomatic treatment. On the basis of this, the observation group was given Tanreqing injection combined with azithromycin The patients in the control group were treated with azithromycin. The clinical symptoms, laboratory parameters, the changes of X-ray examination results, the occurrence of adverse reactions, the fever subsidence time, the disappearance of rales and the disappearance of cough were observed in the two groups. Results: The total effective rate was 98.00% in the observation group and 80.00% in the control group. The total effective rate in the two groups was statistically significant (P <0.05). The observation group fever regression time, rales disappear time and cough disappear time compared with the control group, the difference was statistically significant (P <0.01). The incidence of adverse reactions in the observation group was 12.00%, which was significantly lower than that in the control group (30.00%), the difference was statistically significant (P <0.05). Conclusion: Tanreqing injection combined with azithromycin in children with Mycoplasma pneumoniae pneumonia can effectively improve the therapeutic effect, and the symptoms relieved quickly, with fewer adverse reactions, has a high value.